Yunping Hu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
Papers in
-
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 8
Yunping Hu
78 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 1.0k
- Molecular Biology 1.8k
- Oncology 444
- Toxicology 44
- Pharmacology 92
Countries citing papers authored by Yunping Hu
This map shows the geographic impact of Yunping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunping Hu more than expected).
Fields of papers citing papers by Yunping Hu
This network shows the impact of papers produced by Yunping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunping Hu. The network helps show where Yunping Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yunping Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 19 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 36 | |
| 7 | 2022 | 9 | |
| 8 | 2021 | 32 | |
| 9 | 2021 | 19 | |
| 10 | 2020 | 54 | |
| 11 | 2020 | 12 | |
| 12 | 2019 | 141 | |
| 13 | 2018 | 78 | |
| 14 | 2018 | 86 | |
| 15 | 2017 | 22 | |
| 16 | 2017 | 72 | |
| 17 | 2014 | 21 | |
| 18 | 2014 | 77 | |
| 19 | 2007 | 25 | |
| 20 | 2005 | 34 |
About Yunping Hu
Yunping Hu is a scholar working on Cancer Research, Applied Microbiology and Biotechnology, Oncology, Molecular Biology and Aging, having authored 78 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), MicroRNA in disease regulation (8 papers), RNA modifications and cancer (7 papers), Nanoplatforms for cancer theranostics (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Natural product bioactivities and synthesis (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (1.8k citations), Oncology (444 citations), Toxicology (44 citations) and Pharmacology (92 citations). Yunping Hu has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Yingbin Liu, Maolan Li, Xiangsong Wu, Lin Jiang, Yijian Zhang, Xiaoling Song, Lin Jiang, Hao Weng, Shanshan Xiang and Yang Cao. Their work appears in journals such as Cancer Letters, Cell Death and Disease, International Journal of Biological Sciences, Oncotarget and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.